rHSA/GCSF

DRUG2 trials

Sponsors

Tianjin SinoBiotech Ltd.

Conditions

CancerCancer, BreastChemotherapy-induced NeutropeniaTumorUnderdose (Unintentional)

Phase 1

Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

CompletedNCT01919710

Tianjin SinoBiotech Ltd.Cancer, Tumor, Underdose (Unintentional)

Start: 2012-10-31End: 2014-08-31Updated: 2015-06-03

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

CompletedNCT03246009

Tianjin SinoBiotech Ltd.Cancer, Breast, Chemotherapy-induced Neutropenia

Start: 2016-01-21End: 2017-04-10Updated: 2017-08-11

Related Papers

Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.

2021-03-312 citations